Good Distribution Practices

The distribution and transport of medicines and active ingredients (APIs) are key activities in the supply chain

The Pharmaceutical Industry, as well as regulatory agencies, are increasing efforts to ensure that active substances and medicines are properly managed throughout the supply chain

Distribution Practices

Globalization and offshoring of the pharmaceutical industry means that the supply chain for medicines and active ingredients is increasingly complex and involves a greater number of agents

In this environment, the distribution and transport of medicines and active ingredients (APIs) for human use are key supply chain activities that must be controlled in order to maintain the quality and integrity of the medicines, as set forth in the European regulations, 2011/62/EU and related Guides 2013/C 343/01 and 2015/C 95/01, as well as current FDA initiatives and expectations.

Control of the Supply Chain

Rephine’s wide experience working both with pharmaceutical laboratories and directly with the main actors involved in the supply chain, allows us to address different risk management strategies and to easily respond to issues.

Characterisation of the Supply Chain

How to identify all the actors involved in the supply chain?

What controls should be established along the supply chain?

Identification of the Agents

Who should have a GDP certificate for the distribution or transport of medicines?

What is a GDP certificate and who can issue it?

Definition of Responsibilities

How responsibilities along the supply chain should be defined?

Good Distribution Practices Services

Advice and compliance with GDP for distributors and transporters
Optimization of the supply chain and improvement of control in the supply chain through a risk management approach
Preparation of regulatory inspections, for the authorization of facilities
Qualification of facilities and warehouse utilities
Advise and preparation of the Quality System for logistics and distribution operations.

The distribution and transport of medicines and active ingredients (APIs) are key activities in the supply chain.

Project Compliance Lifecycle

Where do you Need our Help?

For GMP Auditing, Quality Assurance & Digitalisation, we’re the partner of choice for all the stakeholders we deal with.

We provide extensive GMP consulting services to help keep our clients ahead of the needs and expectations of regulators.

Global Audit Library

Explore our extensive GMP audit library to see the range and scope of live reports we have in stock, join a live audit, or commission a bespoke audit

GMP Audit Services

Maintain high standards of life sciences manufacturing supplier qualifications and GMP auditing within the supply chain through our expertise

GxP Consultancy

Discover how we can help your product reach to market, fully and demonstrably complying with the latest GxP standards

Digitalisation

From data integrity to implementing new systems, our experienced team with a digital mindset, can lead you to transformative achievements

Related Resources

SAP PALEX CSV Case Study Header Image (1500 x 844 px)

Article

Change Management in CSV Projects: A GxP Guide

Every change to a validated system carries risk. Discover the core components, roles and best practices that keep Change Management in CSV projects controlled, compliant ...

ICH E6 Guide Header Image (1500 x 844 px)

Case Study

From Cosmetics to OTC: Full FDA GMP Compliance Achieved in 12 Months

A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full ...

Close up of nurse holding and typing on tablet

CSV

Data Integrity Remediation: A Practical Framework for Pharma

Turn data integrity findings into a sustainable, risk based remediation plan. A practical 7 phase framework for pharma labs.

Article

GDP Transport Validation: A Practical Guide for Pharmaceutical Companies

Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide ...

Ensuring Compliance and Data Integrity in Pharmacovigilan

CSV

Validation in the New Pharma Reality: Compliance, Digitalisation and AI Under Rising Regulatory Pressure

Watch our webinar with Rephine and ValGenesis on modern, inspection-ready validation: what EU GMP Annex 11 and ALCOA+ now expect, and where AI fits in ...

CSV

Building Inspection-Ready Validation for a Digital, AI-Enabled World

Now watching on-demand: Rephine and ValGenesis on modern, inspection-ready validation, where AI helps in GxP, and what EU GMP Annex 11 and ALCOA+ really expect.

Article

Digital Solution Selection in Regulated Environments: Beyond Software Features

Feature lists do not guarantee a successful digital transformation. Discover why a structured, business-led selection process is the real driver of compliance, adoption and long-term ...

Article

Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide

The EU veterinary sector enters a new era on 16 July 2026. Dedicated GMP regulations replace EudraLex Volume 4 for veterinary products. Learn what changes ...

Article

MDR & IVDR Compliance: A Strategic Approach for MedTech

Regulatory compliance under MDR and IVDR has moved beyond documentation to become a strategic discipline that shapes every stage of a medical device's lifecycle. This ...

Let's get in touch

Please get in touch. Our expert GMP audit team is only a click away, on standby to answer all your questions.

Email: [email protected]

Social:

REPHINE HQ

Stevenage, UK
+44 1763 853135

REPHINE BARCELONA S.L.U

Barcelona, Spain
+34 934 178065

REPHINE CHINA

Shanghai, China

REPHINE INDIA

Hyderabad, India

First Name

Last Name

Phone

Country

Company

Job Title

Interested In

Message

Marketing Opt In

Rephine respects your privacy. Choosing to check the box means that you agree to the Rephine Privacy Policy. You can unsubscribe at any time.

GMP Audit Services

GxP Consultancy

Good Distribution Practices

The distribution and transport of medicines and active ingredients (APIs) are key activities in the supply chain

Distribution Practices

Globalization and offshoring of the pharmaceutical industry means that the supply chain for medicines and active ingredients is increasingly complex and involves a greater number of agents

Control of the Supply Chain

Rephine’s wide experience working both with pharmaceutical laboratories and directly with the main actors involved in the supply chain, allows us to address different risk management strategies and to easily respond to issues.

Characterisation of the Supply Chain

Identification of the Agents

Definition of Responsibilities

Good Distribution Practices Services

Project Compliance Lifecycle

Where do you Need our Help?

For GMP Auditing, Quality Assurance & Digitalisation, we’re the partner of choice for all the stakeholders we deal with.

Global Audit Library

GMP Audit Services

GxP Consultancy

Digitalisation

Related Resources

Let's get in touch

Strengthen Your Assurance Journey